NCT06618872View on ClinicalTrials.gov

Incremental Diagnostic Value of Tau-PET with [18F]RO948 Vs Amyloid-PET in Patients with Cognitive Impairment

NARecruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

December 9, 2024

Primary Completion Date

August 30, 2027

Study Completion Date

August 30, 2027

Conditions
DementiaAlzheimer Disease
Interventions
DIAGNOSTIC_TEST

PET/CT with RO958 (experimental)

the participant will have 2 PET (one with an experimental radiotracer- Tau PET), one with a standard radiotracer (amyloid-PET)

Trial Locations (2)

1205

RECRUITING

Geneva University Hospital, Geneva

1211

NOT_YET_RECRUITING

Centre Medical Universitaire Vaudois, Lausanne

All Listed Sponsors
collaborator

Centre Hospitalier Universitaire Vaudois

OTHER

lead

University Hospital, Geneva

OTHER